Cellcolabs
Cellcolabs is a biotech impact start-up specializing in industrial GMP production of high quality stem cells (mesenchymal stromal cells) in order to make them available at scale. Their ultimate goal is to accelerate stem cell research and make the treatments of the future available for all.
Why Cellcolabs has the best-in-class offerings?
- GMP-ATMP approved facility and production process to ensure the remarkable quality from Sweden.
- The facility comprises three state-of-the-art clean rooms that are staffed by experienced production personnel and world-leading affiliated scientists.
- The production process involves culturing stem cells in a Xeno-free environment, which ensures high and consistent quality for every batch.
- Cellcolabs continuously invests in R&D projects to optimize the production process and improve overall efficiency
Selected Publications
1. Le Blanc K, Tammik C, Sundberg B, Haynesworth S, Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 2003; 57; 11-20. Cited 1 028 times.
2. Le Blanc K, Tammik L, Zetterberg E, Rosendahl K, Ringdén O. HLA-expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol, 2003; 31: 890-896. Cited 1 228 times.
